Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy

This study has been terminated.
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by:
French National Agency for Research on AIDS and Viral Hepatitis
ClinicalTrials.gov Identifier:
NCT00127569
First received: August 4, 2005
Last updated: January 11, 2007
Last verified: January 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: January 2006
  Estimated Primary Completion Date: No date given